Applying host disease status biomarkers to therapeutic response monitoring in invasive aspergillosis patients.

@article{Zhao2018ApplyingHD,
  title={Applying host disease status biomarkers to therapeutic response monitoring in invasive aspergillosis patients.},
  author={Yanan Zhao and Yoji Nagasaki and Padmaja Paderu and Michele W. Sugrue and Helen L. Leather and John R Wingard and David Scott Perlin},
  journal={Medical mycology},
  year={2018}
}
One critical factor impeding successful management of invasive aspergillosis (IA) is the lack of reliable biomarkers to assess therapeutic response. We hypothesized that changes in certain host biomarkers reflect the nature of infection status and disease progression. Upon primary IA diagnosis, these disease status biomarkers can be monitored to track response to antifungal therapy and provide early markers that prognosticate likelihood of response. Herein, we analyzed serum levels of three… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 6 times over the past 90 days. VIEW TWEETS